Studying the Relationship Between Fitness and Myeloma Progression image

Studying the Relationship Between Fitness and Myeloma Progression

Sep 02, 2021
07:00PM - 07:45PM EDT
Online Event
Overview

Join Dr. Jens Hillengass as he shares early information about his study between fitness and myeloma progression in smoldering myeloma patients. Learn what you can do to help accelerate this field of research. 

Agenda
07:00 PM
Introduction
Audrey Burton-Bethke
Audrey welcomes everyone, introduces our featured speaker, and shares the event agenda.  
07:05 PM
Presentation
Dr. Jens Hillengass
Dr. Hillengass shares early information about his study between fitness and myeloma progression in smoldering myeloma patients.
07:25 PM
Q & A
Audience
Dr. Hillengass answers the audience's questions about the about his presentation and related topics.
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Jens Hillengass, MD

Jens Hillengass, MD

Jens Hillengass, MD, PhD, is Professor of Oncology and Chief of the Myeloma and Amyloidosis Service at Roswell Park Cancer Institute in Buffalo, NY. Prior to joining Roswell, he was the deputy of the section multiple myeloma of the University Hospital of Heidelberg, Germany, the leader of its autologous stem cell transplantation program, and head of the hemato-oncological imaging research group at the German Cancer Research Center (DKFZ). He completed his medical degree at Heidelberg University, where he later completed residency and fellowship in the department of hematology, oncology, and rheumatology. Dr Hillengass received a Gerok scholarship to study radiology at the German Cancer Research Center. Additionally, he completed a research fellowship at the National Cancer Institute. Dr. Hillengass is member of the Black Swan Research Initiative of the International Myeloma Foundation and the International Myeloma Working Group where he co-chairs the bone and imaging group.